E-LIB Suche - Ergebnisse für: İlhan, H.

1

Early prediction of endocrine responsiveness in ER+/HER2-ne..:

Gennari, A. ; Brain, E. ; De Censi, A....
Annals of Oncology. 35 (2024) 6 - p. 549-558 , 2024

Link: https://doi.org/10.1016/..

2

BRCA 1/BRCA 2 Pathogenic/Likely Pathogenic Variant Patients..:

Osman, K. ; Ahmet, K. ; Hilmi, T....
Balkan Journal of Medical Genetics. 25 (2023) 2 - p. 5-14 , 2023

Link: https://doi.org/10.2478/..

3

MO-0221 Intraprostatic GTV delineation in 18F-PSMA-PET Imag..:

Holzschuh, J. ; Mix, M. ; Ruf, J....
Radiotherapy and Oncology. 182 (2023) - p. S154-S155 , 2023

Link: https://doi.org/10.1016/..

4

PD-0810 Salvage Therapies for PSMA PET/CT-positive nodal-on..:

Schmidt-Hegemann, N. ; Trapp, C. ; Rogowski, P....
Radiotherapy and Oncology. 161 (2021) - p. S643-S644 , 2021

Link: https://doi.org/10.1016/..

5

Salvage Therapies for PSMA PET/CT-positive nodal-only recur..:

Kretschmer, A. ; Milow, J. ; Buchner, A....
European Urology. 79 (2021) - p. S1171 , 2021

Link: https://doi.org/10.1016/..

6

Thermodynamic and Kinetic Parameters of Thermostable Alkali..:

Çelik, S. Y. ; Ilhan, H.
Russian Journal of Bioorganic Chemistry. 47 (2021) 1 - p. 236-243 , 2021

Link: https://doi.org/10.1134/..

7

Optimierung der 223Radium-Dichlorid-Therapie von Patienten ..:

Ilhan, H. ; Stegger, L. ; Dietlein, M....
best practice onkologie. 16 (2021) 11 - p. 494-506 , 2021

Link: https://doi.org/10.1007/..

8

PSMA-basierte Theranostik beim Prostatakarzinom: Von der Bi..:

Ilhan, H. ; la Fougère, C. ; Krause, B. J.
best practice onkologie. 15 (2020) 11 - p. 498-507 , 2020

Link: https://doi.org/10.1007/..

9

Image-based dosimetry for 225Ac-PSMA-I&T therapy using quan..:

Gosewisch, A. ; Schleske, M. ; Gildehaus, F. J....
European Journal of Nuclear Medicine and Molecular Imaging. 48 (2020) 4 - p. 1260-1261 , 2020

Link: https://doi.org/10.1007/..

10

Recent advances of PET imaging in clinical radiation oncolo..:

Unterrainer, M. ; Eze, C. ; Ilhan, H....
Radiation Oncology. 15 (2020) 1 - p. , 2020

Link: https://doi.org/10.1186/..

11

Salvage therapies for PSMA PET-positive nodal recurrent pro..:

Kretschmer, A. ; Buchner, A. ; Eze, C....
European Urology Open Science. 19 (2020) - p. e1219 , 2020

Link: https://doi.org/10.1016/..

12

PSMA-basierte Theranostik beim Prostatakarzinom: Von der Bi..:

Ilhan, H. ; la Fougère, C. ; Krause, B. J.
Der Urologe. 59 (2020) 5 - p. 617-625 , 2020

Link: https://doi.org/10.1007/..

13

18F-PSMA-1007 PET/CT for response assessment in patients wi..:

Mittlmeier, L. M. ; Unterrainer, M. ; Rodler, S....
European Journal of Nuclear Medicine and Molecular Imaging. 48 (2020) 6 - p. 2031-2037 , 2020

Link: https://doi.org/10.1007/..

14

Advanced Molecular Imaging in Histologically Verified Metan..:

Mittlmeier, L.M. ; Unterrainer, M. ; Todica, A....
Urology. 140 (2020) - p. e10-e11 , 2020

Link: https://doi.org/10.1016/..

15

PSMA PET/CT for tyrosine-kinase inhibitor monitoring in met..:

Mittlmeier, L. M. ; Unterrainer, M. ; Todica, A....
European Journal of Nuclear Medicine and Molecular Imaging. 47 (2020) 9 - p. 2216-2217 , 2020

Link: https://doi.org/10.1007/..